Novartis Ag (NVSEF) EBITDA Margin (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) EBITDA Margin (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -7,391.00
Mar 31, 2023 -902.00
Dec 31, 2022 -5,227.00
Sep 30, 2022 14,231.00
Jun 30, 2022 -13,588.00
Mar 31, 2022 15,179.00
Dec 31, 2021 -19,317.00
Sep 30, 2021 16,784.00
Jun 30, 2021 -8,418.00
Mar 31, 2021 -4,269.00
Dec 31, 2020 -1,225.00
Sep 30, 2020 14,524.00
Jun 30, 2020 3,956.00
Jun 30, 2019 -9,353.00
Mar 31, 2019 1,222.00
Dec 31, 2018 -3,644.00
Sep 30, 2018 12,151.00
Jun 30, 2018 -17,405.00
Mar 31, 2018 4,193.00
Dec 31, 2017 -5,213.00